Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by BARTNIK, F. G.
Right arrow Articles by KUNSTLER, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BARTNIK, F. G.
Right arrow Articles by KUNSTLER, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 Oxford University Press

research-article

Percutaneous Absorption, Metabolism, and Hemolytic Activity of n-Butoxyethanol

F. G. BARTNIK*, A. K. REDDY{dagger}, G. KLECAK{ddagger}, V. ZIMMERMANN*, J.J. HOSTYNEK{dagger} and K. KUNSTLER*

*Henkel KGAA Dusseldorf, West Germany {dagger}Clorox Technical Center Pleasanlon, California 94566 {ddagger}F. Hoffman-LaRoche & Company Ltd. Basel, Switzerland

Percutaneous Absorption, Metabolism, and Hemolytic Activity of n-Butoxyethanol. BARTNIK, F. G., REDDY, A. K., KLECAK, G., ZIMMERMANN, V., HOSTYNEK, J. J., and KUNSTLER, K. (1987). Fundam. Appl. Toxicol. 8, 59–70. A series of studies was conducted to examine the percutaneous absorption, distribution, excretion, and hemolytic activity of n-butoxyethanol (BE). Rats receiving a subcutaneous dose of 14C-labeled BE excreted the radioactivity in the urine (79%), expired air (10%), and feces (0.5%) within 72 hr. Of the organs analyzed, thymus and spleen showed elevated specific radioactivities as compared with blood. A percutaneous application of BE on rats, under nonocclusive conditions, showed 25–29% absorption within 48 hr. Peak blook levels of BE occurred at 2 hr after application; butoxyacetic acid (BAA) was found to be the major metabolite. Comparison of in vitro skin penetration data showed the following absorption pattern of BE: hairless rat >> pig > human skin. Hemolysis and associated hematological changes were noted in the rats which received single dermal applications of 260–500 mg/kg of BE. In vitro, BAA showed markedly greater hemolytic ability on rat erythrocytes than did BE. Human erythrocytes showed no hemolysis when incubated with BE or BAA at concentrations that are hemolytic to rat erythrocytes. An intravenous dose of 62.5 mg/kg of BE does not result in hemolysis or hemoglobinuria in the rat. The rat may be an animal model with increased susceptibility to the effects of BE compared with humans because of its rapid percutaneous absorptive ability and its greater hemolytic sensitivity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.